Modelling vaccination strategies for COVID-19COVID-19에 대한 백신 접종 전략 모델링Article Published on 2022-03-012022-09-11 Journal: Nature reviews. Immunology [Category] SARS, 변종, [키워드] applied booster dose booster doses can be used coronavirus disease Coronavirus disease 2019 COVID-19 Critical distribution effective vaccine Factor Health Health policy immunological limit mathematical model Mathematical models parameter predictive power Safe SARS-CoV-2 vaccination against COVID-19 Vaccination strategy [DOI] 10.1038/s41577-022-00687-3 PMC 바로가기 [Article Type] Article
SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum womenSARS-CoV-2 mRNA 백신은 산후 여성과 비 산후 여성에서 우려되는 변이체에 대해 더 높은 항체 친화도 및 IgG 역가를 유도했습니다.Article Published on 2022-03-012022-09-11 Journal: EBioMedicine [Category] MERS, SARS, 변종, 진단, [키워드] affinity Affinity maturation Amino acid amino acids antibody antibody affinity Antibody binding antibody neutralisation titres Beta both groups characterisation comparable controls countermeasure COVID-19 declined Delta described domain FDA groups help IgG titer immune response immune responses in both groups initiative knowledge Limited manuscript mRNA mRNA vaccine mutant neutralisation neutralisation titre neutralising ability plasma plasma antibody profile RBD SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants significantly higher spike supported sustained tested vaccination Vaccination strategies Vaccination strategy Vaccine vaccine-induced antibody response variants of concern VoC VOCs women [DOI] 10.1016/j.ebiom.2022.103940 PMC 바로가기 [Article Type] Article
Community seroprevalence and risk factors for SARS-CoV-2 infection in different subpopulations in Vellore, India, and their implications for future prevention인도 Vellore의 다양한 하위 집단에서 SARS-CoV-2 감염에 대한 커뮤니티 혈청 유병률 및 위험 요소 및 향후 예방에 대한 의미Article Published on 2022-03-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, [키워드] 95% CI Asymptomatic coronavirus COVID diabete Endemic heterogeneous highest hypertension IgG antibody IgG positivity implication India individual majority multivariable analyses pandemic Participants Population population immunity public health reached residence risk factor SARS-CoV-2 SARS-COV-2 infection second wave seropositive seropositive individual Seroprevalence subpopulation subpopulations suggested vaccination Vaccination strategy [DOI] 10.1016/j.ijid.2021.12.356 PMC 바로가기 [Article Type] Article
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy항-CD20 치료 이력이 있는 환자에서 체액성 및 세포성 면역의 궤적과 SARS-CoV-2에 대한 3차 mRNA 백신에 대한 반응Article Published on 2022-03-012022-09-11 Journal: RMD Open [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] Analysis anti-CD20 anti-CD20 therapy anti-CD20 treatment anti-SARS-CoV-2 immune response anti-SARS-CoV-2 immune responses antibody concentration Antibody concentrations cell-mediated immune Cell-mediated immunity cellular immunity CMI comparable Concentration Control covariance COVID-19 decay dose elicited healthy volunteer healthy volunteers humoral humoral and cell-mediated immunity Humoral response humoral responses IgG immune responses Immunity immunogenicity inefficient interferon interferon-γ investigated Linear regression majority mRNA vaccine non-responder non-responders outcome Participants Patient patients registration number Responder responders response reveal rituximab RNA SARS-CoV-2 SARS-CoV-2 vaccine second vaccination systemic vasculitis Therapies therapy Trajectories trajectory Trial Registration Number vaccination Vaccination strategy Vaccine vaccine dose Vasculitis [DOI] 10.1136/rmdopen-2021-002166 PMC 바로가기 [Article Type] Article
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic팬데믹 초기에 감염된 환자에서 SARS-CoV-2 Delta 변이체에 대한 중화 항체 반응의 동역학Article Published on 2022-02-282022-09-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] Against Asymptomatic Course COVID-19 Delta delta variant detectable FRNT Infection investigated Kinetics natural infection Neutralizing antibody response neutralizing antibody responses neutralizing response neutralizing responses pandemic Patient respiratory response SARS-CoV-2 Severe acute respiratory syndrome severe disease severity undetectable Vaccination strategy variant wild type [DOI] 10.3346/jkms.2022.37.e67 PMC 바로가기 [Article Type] Article
A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity내열성 경구 SARS-CoV-2 백신은 점막 및 보호 면역을 유도합니다Article Published on 2022-02-252022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] addition Administered administration antibody boost cellular Complete COVID-19 criteria Degradation effective expressing expression form Giardia lamblia hamsters IgA immune response induce injected intestinal intramuscularly Logistic membrane protein mice mucosal mucosal immunity Neutralizing oral oral vaccination platform pre-fusion preventing disease Protective Protein responses against robust SARS-CoV-2 spike surface protein the SARS-CoV-2 thermostable translate Trigger triggering Vaccination strategy Vaccine Vaccines viral challenge virus transmission Virus-like particle VLP VLP (virus-like particle) [DOI] 10.3389/fimmu.2022.837443 PMC 바로가기 [Article Type] Article
DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice엔벨로프 및 막 단백질을 발현하는 DNA 백신은 생쥐에서 SARS-CoV-2에 대한 부분적 보호를 제공합니다Article Published on 2022-02-242022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Against caused cellular Cellular immune response cellular response conserved coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cross-protective DNA DNA vaccine dose effective Electroporation elicited envelope envelope protein Epitopes humoral Humoral immunity Humoral response immune responses immunisation International Intramuscular injection lung tissue membrane membrane protein mice pandemic Partial protection Protein provided public health emergency respiratory robust SARS-CoV SARS-CoV-2 severe acute respiratory syndrome Coronavirus Significant structural protein structural proteins T-cell epitope target titre Vaccination strategies Vaccination strategy Vaccine vaccine candidate vaccine candidates Vaccines virus [DOI] 10.3389/fimmu.2022.827605 PMC 바로가기 [Article Type] Article
Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean IndividualsArticle Published on 2022-02-182022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibody Antibody Response BNT162b2 Complete convalescent COVID-19 COVID-19 vaccination COVID-19 vaccine dose ELISA ELISPOT evaluated IFN-γ ELISPOT immune response increase in individual individuals Korean mRNA-1273 mRNA-1273 vaccine much lower no significant difference pseudotyped pVNT50 regimen regimens required response S1 IgG SARS-CoV-2 SARS-COV-2 infection significantly higher single dose the mean the vaccine Vaccination strategy Vaccine vaccinee virus-neutralizing antibody were measured [DOI] 10.3390/vaccines10020332 PMC 바로가기 [Article Type] Article
Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis비 약제 개입 및 백신 접종 아동에 의한 호주에서 SARS-COV-2 델타 질병 부담 완화 : 모델링 분석Research Article Published on 2022-02-182022-09-10 Journal: BMC Medicine [Category] COVID19(2023년), Fulltext, MERS, SARS, 변종, [키워드] activating Activation age Analysis appear assumed benefit BNT162b2 BNT162b2 Pfizer Border can not children country Coverage COVID-19 COVID-19 vaccination death Delta delta variant determine disease Effectiveness evaluate evaluated exceeded feasible Health healthcare facility hospitalisation hospitalisations Immunity include Increases Infection intensive care International Intervention measure Measures Mitigation strategy effectiveness modelling moderate Non-pharmaceutical measures NPI NPIs outbreak physical distancing predicted Prevent quantified reduce reduction in reductions reductions in Result resulting Revised 2nd January 2022 SARS-CoV-2 SARS-CoV-2 transmission shown supplementary material suppress the SARS-CoV-2 Transmission Travel vaccination Vaccination strategies Vaccination strategy Vaccine was used [DOI] 10.1186/s12916-022-02241-3 PMC 바로가기 [Article Type] Research Article
Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2Article Published on 2022-02-162022-10-29 Journal: Scientific Reports [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] age average basic reproduction number Computational models Contact country Coverage Critical Endemic fraction greater group heterogeneous Immunity Infection Infectious diseases influence initial Population required SARS-CoV-2 social contact susceptible individual vaccinated against COVID-19 vaccination vaccination rate Vaccination strategy Vaccine vaccine dose Vaccines waning immunity [DOI] 10.1038/s41598-022-06477-0 PMC 바로가기 [Article Type] Article